Simergent
Private Company
Funding information not available
Overview
Simergent is a private, pre-revenue medical device startup founded in 2019 and based in San Francisco, developing the Archimedes™ automated peritoneal dialysis system. The device is engineered to be more patient-centric, with features targeting reduced peritonitis risk, lower fill/drain pressures, minimal setup time, and enhanced mobility to allow a more normal life. Led by a team with deep expertise in PD device development and nephrology, and backed by incubators and venture capital, the company is positioning itself to capture share in the large and growing global home dialysis market, particularly in cost-sensitive emerging regions.
Technology Platform
Archimedes™ automated peritoneal dialysis (APD) system featuring patented low-pressure fill/drain cycles, patented solution line connectors for reduced infection risk, and a user-centric design for mobility and ease of use.
Opportunities
Risk Factors
Competitive Landscape
The market is dominated by large, established players like Baxter International and Fresenius Medical Care, which offer their own APD cyclers. Simergent's competition is based on a differentiated design targeting superior usability, patient comfort, and potential safety benefits, aiming to capture share in niche and emerging markets first.